title: Is adjuvant chemotherapy useful in lobular breast cancer patients?
authors.affiliation: Departments of Radiotherapy.
authors.forename: X
authors.initials: X
authors.lastname: Liem
authors.affiliation: Pathology.
authors.forename: M C
authors.initials: MC
authors.lastname: Baranzelli
authors.affiliation: General Oncology.
authors.forename: N
authors.initials: N
authors.lastname: Penel
authors.affiliation: Breast Cancer, Centre Oscar Lambret, Lille.
authors.forename: S
authors.initials: S
authors.lastname: Giard
authors.affiliation: Breast Cancer, Centre Oscar Lambret, Lille; Breast Unit, Université de Lille-Nord de France, Lille, France. Electronic address: j-bonneterre@o-lambret.fr.
authors.forename: J
authors.initials: J
authors.lastname: Bonneterre
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D018275:Carcinoma, Lobular / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D012189:Retrospective Studies
chemical_list: D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil